Topics

TCT 2019: TRILUMINATE Six-Month Results Support Abbott’s TriClip

06:53 EDT 3 Oct 2019 | SCRIP

<p>The six-month results of the TRILUMINATE Feasibility trial support the safety and effectiveness of Abbott’s TriClip, a version of the...

      

Related Stories

 

Original Article: TCT 2019: TRILUMINATE Six-Month Results Support Abbott’s TriClip

NEXT ARTICLE

More From BioPortfolio on "TCT 2019: TRILUMINATE Six-Month Results Support Abbott’s TriClip"

Quick Search

Relevant Topic

Abbott
The 11th largest pharmaceutical company in the world, <!--LGfEGNT2Lhm-->Abbott Laboratories generated sales of $16 billion in 2009 and has 90,000 employees. Within the <!--LGfEGNT2Lhm-->medical device arm of the company, products of note ar...